BACKGROUND: A growing body of research is using deep learning to explore the relationship between treatment biomarkers for lung cancer patients and cancer tissue morphology on digitized whole slide images (WSIs) of tumour resections. However, these W...
Cancer, a global health threat, demands effective diagnostic solutions to combat its impact on public health, particularly for breast, colon, and lung cancers. Early and accurate diagnosis is essential for successful treatment, prompting the rise of ...
BMC medical informatics and decision making
Dec 4, 2024
BACKGROUND: The digitisation of healthcare records has generated vast amounts of unstructured data, presenting opportunities for improvements in disease diagnosis when clinical coding falls short, such as in the recording of patient symptoms. This st...
Lung cancer (LC) remains one of the leading causes of cancer-related mortality worldwide. With recent technological advances, artificial intelligence (AI) has begun to play a crucial role in improving diagnostic and treatment methods. It is crucial t...
The high burden of lung diseases on healthcare necessitates effective detection methods. Current Computer-aided design (CAD) systems are limited by their focus on specific diseases and computationally demanding deep learning models. To overcome these...
IEEE transactions on neural networks and learning systems
Dec 2, 2024
Accurate lung lesion segmentation from computed tomography (CT) images is crucial to the analysis and diagnosis of lung diseases, such as COVID-19 and lung cancer. However, the smallness and variety of lung nodules and the lack of high-quality labeli...
PURPOSE: Artificial intelligence (AI) algorithms for lung nodule detection have been developed to assist radiologists. However, external validation of its performance on low-dose CT (LDCT) images is insufficient. We examined the performance of the co...
Journal of applied clinical medical physics
Nov 29, 2024
BACKGROUND: Lung cancer poses a significant global health challenge. Adaptive radiotherapy (ART) addresses uncertainties due to lung tumor dynamics. We aimed to investigate a comprehensively and systematically validated offline ART regimen with high ...
Gefitinib resistance (GR) presents a significant challenge in treating lung adenocarcinoma (LUAD), highlighting the need for alternative therapies. This study explores the genetic basis of GR to improve prediction, prevention, and treatment strategie...
BACKGROUND: Lung adenocarcinoma (LUAD) is a heterogeneous tumor characterized by diverse genetic and molecular alterations. Developing a multi-omics-based classification system for LUAD is urgently needed to advance biological understanding.
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.